View Agent
| Agent Info | |
| Agent: | AZD9291 |
| Synonyms: | NA |
| Drug Status For Certain Diseases: | phase III(melanoma) |
| Classification: | 3rd-generation, mutant-selective, irreversible EGFR inhibitors |
| Target: | Epidermal growth factor receptor |
| KEGG Pathway: | NA |
| Wiki Pathway: | Focal Adhesion Hair Follicle Development Gastric cancer network 2 L1CAM interactions Signaling by ERBB4 Nanoparticle-mediated activation of receptor signaling miR-targeted genes in lymphocytes - TarBase EGF/EGFR Signaling Pathway Extracellular vesicle-mediated signaling in recipient cells Regulation of Actin Cytoskeleton MAPK Signaling Pathway Signaling Pathways in Glioblastoma Arylhydrocarbon receptor (AhR) signaling pathway Integrated Breast Cancer Pathway Signaling by EGFR Bladder Cancer Hair Follicle Development Aryl Hydrocarbon Receptor Pathway miR-targeted genes in epithelium - TarBase Spinal Cord Injury Aryl Hydrocarbon Receptor TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer miR-targeted genes in muscle cell - TarBase Integrated Pancreatic Cancer Pathway PIP3 activates AKT signaling AGE/RAGE pathway Gastrin-CREB signalling pathway via PKC and MAPK ErbB Signaling Pathway Signaling by ERBB2 (WikiPathways) |